gms | German Medical Science

104th DOG Annual Meeting

21. - 24.09.2006, Berlin

Article

Send article

Enucleation with unwrapped porous polyethylene (Medpor) orbital implants: a 6-year experience

Meeting Abstract

Search Medline for

  • M. Falež - Department of Ophthalmology, Maribor Teaching Hospital
  • L. Vrhovec - Department of Ophthalmology, Maribor Teaching Hospital
  • A. Beharic - Department of Ophthalmology, Maribor Teaching Hospital
  • D. Pahor - Department of Ophthalmology, Maribor Teaching Hospital

Deutsche Ophthalmologische Gesellschaft e.V.. 104. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft (DOG). Berlin, 21.-24.09.2006. Düsseldorf, Köln: German Medical Science; 2006. Doc06dogP247

The electronic version of this article is the complete one and can be found online at: http://www.egms.de/en/meetings/dog2006/06dog769.shtml

Published: September 18, 2006

© 2006 Falež et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.

Outline

Text

Objective

To examine the incidence of orbital complications in patients who underwent primary placement of a porous polyethylene implant (Medpor) after enucleation.

Methods

Retrospective analysis of a series of 38 patients who received unwreapped porous spherical implant with direct suturing of rectus muscles on the implant in the last six years.

Results

The mean age at the time of enucleation was 51,3 years (range 19 to 77 years). Mean follow-up duration in this study was 31,8 months (4 – 64 months). During this period there was no case of orbital celullitis, implant extrusion or significant inflamatory response. In one patient (2,6%) surgical revision was necessary eighteen months after enucleation, because of small exposition of implant after change of ocular prosthesis.

Conclusions

The unwrapped porous polyethylene orbital implants (Medpor) appear to be well tolerated by all age groups with no major complication in primary implantation after enucleation.